182 related articles for article (PubMed ID: 33850577)
1. Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real-world global setting: Results from the Cryo AF Global Registry.
Chun KRJ; Okumura K; Scazzuso F; Keun On Y; Kueffer FJ; Braegelmann KM; Kaur Khelae S; Al-Kandari F; Földesi C;
J Arrhythm; 2021 Apr; 37(2):356-367. PubMed ID: 33850577
[TBL] [Abstract][Full Text] [Related]
2. Cryoballoon ablation for paroxysmal atrial fibrillation in Japan: 2-year safety and efficacy results from the Cryo AF Global Registry.
Kimura M; Kobori A; Nitta J; Hirao K; Shizuta S; Kurita T; Okishige K; Kumagai K; Koyama J; Hiroshima K; Inaba O; Goya M; Yamauchi Y; Kueffer FJ; Becker D; Okumura K
J Interv Card Electrophysiol; 2022 Sep; 64(3):695-703. PubMed ID: 35119586
[TBL] [Abstract][Full Text] [Related]
3. Safety of cryoballoon ablation for the treatment of atrial fibrillation: First European results from the cryo AF Global Registry.
Földesi C; Misiková S; Ptaszyński P; Todd D; Herzet JM; Braegelmann KM; Kueffer FJ; Drephal C; Steinwender C; Zucchelli G; Neuzil P; Chun KRJ
Pacing Clin Electrophysiol; 2021 May; 44(5):883-894. PubMed ID: 33813746
[TBL] [Abstract][Full Text] [Related]
4. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial.
Su WW; Reddy VY; Bhasin K; Champagne J; Sangrigoli RM; Braegelmann KM; Kueffer FJ; Novak P; Gupta SK; Yamane T; Calkins H;
Heart Rhythm; 2020 Nov; 17(11):1841-1847. PubMed ID: 32590151
[TBL] [Abstract][Full Text] [Related]
5. Cryoballoon Catheter Ablation in Korean Patients With Paroxysmal and Persistent Atrial Fibrillation: One Year Outcome From the Cryo Global Registry.
Lim HE; Oh IY; Kueffer FJ; van Bragt KA; On YK
Korean Circ J; 2022 Oct; 52(10):755-767. PubMed ID: 36097833
[TBL] [Abstract][Full Text] [Related]
6. Real-world evidence demonstrates an appropriate atrial fibrillation population for hybrid convergent approach versus stand-alone cryoballoon ablation: A long-term safety and efficacy study.
Lorenzo C; Ortiz-Gonzalez Y; Hill D; Kinaga J; Filart L; Bello D; Duran A; Bott J; Patel S; Sendin MJ; Filart R
J Cardiovasc Electrophysiol; 2024 Jun; ():. PubMed ID: 38898656
[TBL] [Abstract][Full Text] [Related]
7. Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry.
Rordorf R; Scazzuso F; Chun KRJ; Khelae SK; Kueffer FJ; Braegelmann KM; Okumura K; Al-Kandari F; On YK; Földesi C;
J Am Heart Assoc; 2021 Dec; 10(24):e021323. PubMed ID: 34889108
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: Clinical outcomes from the real-world multicenter observational project.
Tondo C; Iacopino S; Pieragnoli P; Molon G; Verlato R; Curnis A; Landolina M; Allocca G; Arena G; Fassini G; Sciarra L; Luzi M; Manfrin M; Padeletti L;
Heart Rhythm; 2018 Mar; 15(3):363-368. PubMed ID: 29107190
[TBL] [Abstract][Full Text] [Related]
9. Cryoballoon catheter ablation versus antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: Rationale and design of the international Cryo-FIRST study.
Hermida JS; Chen J; Meyer C; Iacopino S; Arena G; Pavlovic N; Velagic V; Healey S; Packer DL; Pitschner HF; de Asmundis C; Kuniss M; Chierchia GB
Am Heart J; 2020 Apr; 222():64-72. PubMed ID: 32018203
[TBL] [Abstract][Full Text] [Related]
10. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation.
Kuniss M; Pavlovic N; Velagic V; Hermida JS; Healey S; Arena G; Badenco N; Meyer C; Chen J; Iacopino S; Anselme F; Packer DL; Pitschner HF; Asmundis C; Willems S; Di Piazza F; Becker D; Chierchia GB;
Europace; 2021 Jul; 23(7):1033-1041. PubMed ID: 33728429
[TBL] [Abstract][Full Text] [Related]
11. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.
Packer DL; Kowal RC; Wheelan KR; Irwin JM; Champagne J; Guerra PG; Dubuc M; Reddy V; Nelson L; Holcomb RG; Lehmann JW; Ruskin JN;
J Am Coll Cardiol; 2013 Apr; 61(16):1713-23. PubMed ID: 23500312
[TBL] [Abstract][Full Text] [Related]
12. [Latin-American experience in cryoablation of paroxysmal and persistent atrial fibrillation using second generation cryo-balloon. Acute success and 12 months of follow-up].
Scazzuso F; González JL; Rodríguez G; Coria-Sandoval P; Camargo-Ballestas J; Moreno M; Merriam T; Hemingway L; Muratore C
Arch Cardiol Mex; 2021 Feb; 91(2):208-214. PubMed ID: 33601403
[TBL] [Abstract][Full Text] [Related]
13. Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation.
Pokushalov E; Romanov A; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
J Cardiovasc Electrophysiol; 2013 Mar; 24(3):274-9. PubMed ID: 23210695
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon: Final Results From STOP AF Post-Approval Study.
Knight BP; Novak PG; Sangrigoli R; Champagne J; Dubuc M; Adler SW; Svinarich JT; Essebag V; Hokanson R; Kueffer F; Jain SK; John RM; Mansour M;
JACC Clin Electrophysiol; 2019 Mar; 5(3):306-314. PubMed ID: 30898232
[TBL] [Abstract][Full Text] [Related]
15. Catheter ablation using the third-generation cryoballoon provides an enhanced ability to assess time to pulmonary vein isolation facilitating the ablation strategy: Short- and long-term results of a multicenter study.
Aryana A; Kowalski M; O'Neill PG; Koo CH; Lim HW; Khan A; Hokanson RB; Bowers MR; Kenigsberg DN; Ellenbogen KA;
Heart Rhythm; 2016 Dec; 13(12):2306-2313. PubMed ID: 27503480
[TBL] [Abstract][Full Text] [Related]
16. Cryoballoon catheter ablation or drug therapy to delay progression of atrial fibrillation: A single-center randomized trial.
Ding J; Cheng A; Li P; Yan Y; Shi Y; Xue Z; Sun S; Xu J
Front Cardiovasc Med; 2022; 9():1003305. PubMed ID: 36337878
[TBL] [Abstract][Full Text] [Related]
17. Cryoablation for paroxysmal and persistent AF in patients with structural heart disease and preserved ejection fraction: Clinical outcomes from 1STOP, a multicenter observational project.
Perego GB; Iacopino S; Molon G; Arena G; Verlato R; Pieragnoli P; Curnis A; Allocca G; Nicolis D; Sciarra L; Catanzariti D; Senatore G; Rovaris G; Brasca F; Tondo C;
J Cardiol; 2019 Jul; 74(1):19-26. PubMed ID: 30948185
[TBL] [Abstract][Full Text] [Related]
18. German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data.
Schmidt M; Dorwarth U; Andresen D; Brachmann J; Kuck K; Kuniss M; Willems S; Deneke T; Tebbenjohanns J; Gerds-Li JH; Spitzer S; Senges J; Hochadel M; Hoffmann E
Heart Rhythm; 2016 Apr; 13(4):836-44. PubMed ID: 26681608
[TBL] [Abstract][Full Text] [Related]
19. Verification of a novel atrial fibrillation cryoablation dosing algorithm guided by time-to-pulmonary vein isolation: Results from the Cryo-DOSING Study (Cryoballoon-ablation DOSING Based on the Assessment of Time-to-Effect and Pulmonary Vein Isolation Guidance).
Aryana A; Kenigsberg DN; Kowalski M; Koo CH; Lim HW; O'Neill PG; Bowers MR; Hokanson RB; Ellenbogen KA;
Heart Rhythm; 2017 Sep; 14(9):1319-1325. PubMed ID: 28625929
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of the 2nd generation cryoballoon for pulmonary vein isolation in patients with persistent atrial fibrillation - A sub-study of the randomized trial evaluating single versus dual cryoballoon applications.
Mörtsell D; Jansson V; Malmborg H; Lönnerholm S; Blomström-Lundqvist C
Int J Cardiol; 2019 Mar; 278():120-125. PubMed ID: 30409738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
